Literature DB >> 2751481

Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbits.

F J Clubb1, J M Schmitz, M M Butler, L M Buja, J T Willerson, W B Campbell.   

Abstract

Omega-3 fatty acids have been shown to lower plasma cholesterol and triglyceride concentrations in humans. However, the effects of these fatty acids on the interactions among lipid concentrations, platelet activity, and atherogenesis have not been characterized in humans or in animals with low density lipoprotein (LDL) receptor deficiencies. To test the hypothesis that omega-3 fatty acids exert a protective effect in LDL receptor-deficient animals by lowering hyperlipidemia, reducing platelet aggregation, and reducing the severity of atherosclerosis, we evaluated young homozygous Watanabe heritable hyperlipidemic (WHHL) rabbits that were fed omega-3 fatty acids. One-month-old male and female WHHL rabbits were placed on either a control diet (standard laboratory rabbit chow) or a diet supplemented with Menhaden fish oil (MFO), which contained eicosapentaenoic acid (EPA). Consumption measurements during the 5 months of the study indicated that the MFO-fed group received 150 to 200 mg/kg/day of EPA. Six-month-old, MFO-fed, female WHHL rabbits had significantly lower plasma concentrations of total cholesterol (582 +/- 20 mg/dl vs. 856 +/- 44 mg/dl, control, p less than 0.05) and triglycerides (266 +/- 21 mg/dl vs. 459 +/- 15 mg/dl, control, p less than 0.05), with lower serum/plasma lipoprotein concentrations [very low density lipoprotein (VLDL), LDL, high density lipoprotein (HDL)] compared to control female WHHL rabbits. Male MFO-fed rabbits had only significantly lower VLDLs (46 +/- 9 mg/dl) compared to control male WHHL rabbits (156 +/- 9 mg/dl, p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751481     DOI: 10.1161/01.atv.9.4.529

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  9 in total

Review 1.  n-3 fatty acids and lipoproteins: comparison of results from human and animal studies.

Authors:  W S Harris
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 2.  n-3 fatty acids: antiatherosclerotic effects.

Authors:  R De Caterina; A Zampolli
Journal:  Lipids       Date:  2001       Impact factor: 1.880

3.  Dose response of fish oil versus safflower oil on graft arteriosclerosis in rabbit heterotopic cardiac allografts.

Authors:  K L Yun; J I Fann; M H Sokoloff; L G Fong; G E Sarris; M E Billingham; D C Miller
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

Review 4.  Fish oil and the prevention and regression of atherosclerosis.

Authors:  L M Sassen; J M Lamers; P D Verdouw
Journal:  Cardiovasc Drugs Ther       Date:  1994-04       Impact factor: 3.727

Review 5.  Roles of the WHHL rabbit in translational research on hypercholesterolemia and cardiovascular diseases.

Authors:  Tsutomu Kobayashi; Takashi Ito; Masashi Shiomi
Journal:  J Biomed Biotechnol       Date:  2011-04-19

6.  Antiatherogenic effects of n-3 fatty acids - evidence and mechanisms.

Authors:  Raffaele DE Caterina; Antonella Zampolli
Journal:  Heart Int       Date:  2006-12-15

7.  The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (II) - Contribution to the Development and Validation of the Therapeutics for Hypercholesterolemia and Atherosclerosis.

Authors:  Masashi Shiomi
Journal:  J Atheroscler Thromb       Date:  2019-11-21       Impact factor: 4.928

8.  Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid.

Authors:  R Preston Mason; Peter Libby; Deepak L Bhatt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-26       Impact factor: 8.311

Review 9.  The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction.

Authors:  Xiaowen Wang; Subodh Verma; R Preston Mason; Deepak L Bhatt
Journal:  Curr Diab Rep       Date:  2020-10-23       Impact factor: 4.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.